Make your one-time, tribute, or recurring online gift to support brain tumour patient programs and research today: Donate
Dr. Sabine Mai
Manitoba Institute of Cell Biology, Winnipeg, MB
The proposed study focuses on ependymoma, a childhood brain tumour. At diagnosis, it is not possible to know which child will respond to treatment and which child will recur, i.e. if prognosis is favourable or non-favourable. We have developed quantitative tools that may allow for the distinction of good and poor responders at diagnosis.
These tools involve three-dimensional (3D) imaging of telomeres. Telomeres are the ends of chromosomes; they protect the chromosomes from damage and prevent recombination and fusion with other chromosomes (Mai, 2010). Telomere dysfunction therefore is associated with genomic instability and found in many cancers (Mai and Garini, 2006; Mai, 2010).
The data obtained in this study are quantitatively measured, and the output is expected to be a 3D nuclear telomeric profile of each child’s tumour, indicative of favourable or non-favourable disease and will, in the near future, enable for the first time a choice for specific treatments for each child’s ependymoma.
As we celebrate National Volunteer Week (April 23-29, 2017) we thank all of our 700+ volunteers. Without each contribution, we would not be able to offer the programs, services and events that we do. Each person volunteers in a different way and for different reasons. For Liz, giving back to Brain Tumour Foundation of Canada as a volunteer was a “no brainer”. Learn why Liz, a brain tumour survivor, decided to get involved.Learn more
My advice for anyone else going through a brain tumour...Learn more
Sometimes good comes out of the darkest of times. Sometimes depression isn't depression. Sometimes it's a brain tumour. Holly was...Learn more